PureTech Health (PRTC) Current Deferred Revenue (2019 - 2023)

PureTech Health (PRTC) has 4 years of Current Deferred Revenue data on file, last reported at $1.9 million in Q4 2023.

• Current Deferred Revenue for Q4 2023 came in at $1.9 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2023 was $1.9 million (changed N/A YoY), and the FY2023 annual result was $1.9 million, changed N/A from the prior year.
• Current Deferred Revenue advanced to $1.9 million in Q4 2023 per PRTC's latest filing, from $65000.0 in the prior quarter.
• Over five years, Current Deferred Revenue peaked at $5.5 million in Q4 2019 and troughed at $65000.0 in Q4 2021.
• A 4-year average of $2.2 million and a median of $1.7 million in 2020 frame the typical range for Current Deferred Revenue.
• The sharpest annual moves came in 2020 and 2021: Current Deferred Revenue slumped 73.11% in 2020, then tumbled 95.58% in 2021.
• A 4-year view of Current Deferred Revenue shows it stood at $5.5 million in 2019, then slumped by 73.11% to $1.5 million in 2020, then plunged by 95.58% to $65000.0 in 2021, then soared by 2826.15% to $1.9 million in 2023.
• Business Quant data shows PRTC's Current Deferred Revenue at $1.9 million in Q4 2023, $65000.0 in Q4 2021, and $1.5 million in Q4 2020.